'Manufactured' Babies of Same-Sex Parents May Soon Be Reality
By Beth Greenfield,
Yahoo Parenting
| 02. 26. 2015
[Quotes CGS's Marcy Darnovsky]
Untitled Document
In a world where egg harvesting, gestational surrogacy, genetic selection, and now mitochondrial replacement — aka “three-parent babies,” given final approval in Britain on Tuesday — are realities, it’s not quite as easy as it used to be to find shock value in newfangled IVF methods. But news of yet another fertility breakthrough has been getting attention this week, with some saying it will allow same-sex couples to “manufacture” biological babies.
“It has already caused interest from gay groups because of the possibility of making egg and sperm cells from parents of the same sex,” Jacob Hanna, an Israeli scientist collaborating on the project with Cambridge University professor Azim Surani, told the U.K.’s Sunday Times. He said it could become possible to use the technique to create a baby in just two years.
The latest research has found it possible to create primordial germ cells — cells that will go on to become egg and sperm — by using human embryonic stem cells, explains a Cambridge University press release. “Although this has already been done using...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...